TDAC
NASDAQ · N/A
Translational Development Ac
$10.86
+0.01 (+0.05%)
Open$10.85
Previous Close$10.85
Day High$10.87
Day Low$10.85
52W High$10.95
52W Low$10.32
Volume—
Avg Volume72.9K
Market Cap236.99M
P/E Ratio38.15
EPS$0.28
SectorN/A
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 211.68M | 197.91M | 234.06M |
| Net Income | 7.59M | 7.31M | 8.97M |
| Profit Margin | 3.6% | 3.7% | 3.8% |
| EBITDA | 13.67M | 12.28M | 15.52M |
| Free Cash Flow | 6.88M | 4.06M | 6.97M |
| Rev Growth | +3.0% | +7.4% | -1.8% |
| Debt/Equity | 0.09 | 0.09 | 0.09 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $3.03 | +34.07% | — | 1.75B |
| PICS | Pics Nv | $11.49 | +0.70% | 6.8 | 1.56B |
| DMII | Drugs Made In America Acquis | $10.13 | +0.10% | 75.0 | 644.01M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.75 | +0.55% | 35.3 | 335.10M |
| CEPF | Cantor Equity Partners-Cl A | $10.39 | +0.14% | 57.7 | 593.79M |